Question 1

Does Wells Fargo own CVKD stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Wells Fargo holds 99 shares of CVKD (Cadrenal Therapeutics), worth $331.

Question 2

How many shares of CVKD does Wells Fargo own?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo holds 99 shares of CVKD (Cadrenal Therapeutics).

Question 3

What is Wells Fargo's CVKD position worth?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo's CVKD position is worth $331.

Question 4

When did Wells Fargo first buy CVKD?

Accepted Answer

Wells Fargo first reported CVKD in its Q1 2025 13F and has listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Unchanged	99	0.0%	$331	0.0%	$3.34	0
2026-Q1	Unchanged	99	0.0%	$507	0.0%	$8.13	0
2025-Q4	Unchanged	99	0.0%	$671	0.0%	$6.62	0
2025-Q3	Decreased	99	-1.0%	$1,369	0.0%	$13.42	0
2025-Q2	Unchanged	100	0.0%	$1,205	0.0%	$10.44	0
2025-Q1	New	100	-	$1,763	0.0%	$18.46	17

CVKD6 quarters

CVKD
6 quarters